BiotechTube
Home/Avidicure/Robert Friesen
RF

Robert Friesen

CSO

Avidicure

Therapeutic Areas

OncologyAutoimmune Diseases

Avidicure Pipeline

DrugIndicationPhase
AVC-S-201AML and other blood cancers/solid tumorsPreclinical

Leadership Team at Avidicure

AL
Arthur Lahr
CEO
DD
Dirk De Naeyer
COO
GS
Govert Schouten
CBO
View full Avidicure profile